Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
UPMC Presbyterian
mi
from
Pittsburgh, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
UPMC Presbyterian
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
UPMC Shadyside Hospital
mi
from
Pittsburgh, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
UPMC Shadyside Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Joseph Medical Center
mi
from
Wyomissing, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Joseph Medical Center
mi
from
Wyomissing, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
AnMed Health
mi
from
Anderson, SC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Greenville Memorial Hospital of the Greenville Health System
mi
from
Greenville, SC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Greenville Memorial Hospital of the Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Francis Health System
mi
from
Greenville, SC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Francis Health System
mi
from
Greenville, SC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Turkey Creek Medical Center
mi
from
Knoxville, TN
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Turkey Creek Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
The Methodist Hospital Research Institute
mi
from
Houston, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
The Heart Hospital Baylor Plano
mi
from
Plano, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Methodist Texsan Hospital
mi
from
San Antonio, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Methodist Texsan Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Trinity Mother Frances Hospital Regional Healthcare Center
mi
from
Tyler, TX
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Trinity Mother Frances Hospital Regional Healthcare Center
mi
from
Tyler, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Mary Washington Hospital
mi
from
Fredericksburg, VA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Mary Washington Hospital
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital
mi
from
Bellingham, WA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital
mi
from
Bellingham, WA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Providence Regional Medical Center Everett
mi
from
Everett, WA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Providence Regional Medical Center Everett
mi
from
Everett, WA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St Mary's Medical Center
mi
from
Huntington, WV
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St Joseph Mercy Hospital
mi
from
Ypsilanti, MI
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St Joseph Mercy Hospital
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Pinnacle Health at Harrisburg Hospital
mi
from
Wormleysburg, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health at Harrisburg Hospital
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sutter Medical Center
mi
from
Sacramento, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sutter Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Anthony's Medical Center
mi
from
Saint Louis, MO
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Anthony's Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Royal Brisbane and Women's Hospital
mi
from
Herston,
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Royal Brisbane and Women's Hospital
mi
from
Herston,
Click here to add this to my saved trials
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated:  12/31/1969
Cardiology PC
mi
from
Birmingham, AL
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated: 12/31/1969
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated:  12/31/1969
Sutter Memorial Hospital
mi
from
Sacramento, CA
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated: 12/31/1969
Sutter Memorial Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated:  12/31/1969
Board of Trustees of the Leland Stanford Junior University
mi
from
Stanford, CA
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Status: Enrolling
Updated: 12/31/1969
Board of Trustees of the Leland Stanford Junior University
mi
from
Stanford, CA
Click here to add this to my saved trials